Lundy Steve 4
4 · AspenBio Pharma, Inc. · Filed May 2, 2012
Insider Transaction Report
Form 4
Lundy Steve
DirectorCEO and President
Transactions
- Award
Stock Option (Right to Buy)
2012-04-30+75,000→ 75,000 totalExercise: $0.66Exp: 2022-04-30→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option to purchase 75,000 shares of common stock shall become exercisable as to 50% of the shares on October 30, 2012, as to 8.33% of the shares on November 30, 2012, as to 8.33% of the shares on December 31, 2012, as to 8.33% of the shares on January 31, 2013, as to 8.33% of the shares on February 28, 2013, as to 8.34% of the shares on March 31, 2013, and as to 8.34% of the shares on April 30, 2013.